AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 196 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $126,000 | -74.9% | 10,318 | -73.5% | 0.00% | -86.7% |
| Q1 2019 | $501,000 | -85.8% | 38,870 | -61.6% | 0.02% | -80.3% |
| Q4 2016 | $3,525,000 | +965.0% | 101,290 | +617.0% | 0.08% | +850.0% |
| Q1 2016 | $331,000 | -95.9% | 14,126 | -93.0% | 0.01% | -97.9% |
| Q3 2015 | $8,008,000 | +1280.7% | 201,549 | +2300.8% | 0.38% | +1156.7% |
| Q2 2015 | $580,000 | -62.0% | 8,395 | -70.0% | 0.03% | -59.5% |
| Q1 2015 | $1,528,000 | – | 27,957 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |